4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-055604
Chief Medical Officer sold 12,500 shares at an average $35.49 ($443,608)
- Chief Medical Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2020-10-21 | Option exercise | +7,870 | $1.53 | $12,041 | 37,647 | D |
| Pang Phillip Chief Medical Officer | 2020-10-21 | Option exercise | +2,315 | $1.58 | $3,646 | 39,962 | D |
| Pang Phillip Chief Medical Officer | 2020-10-21 | Option exercise | +2,315 | $5.18 | $11,980 | 42,277 | D |
| Pang Phillip Chief Medical Officer | 2020-10-21 | Sale | −7,500 | $35.42 | $265,657 | 34,777 | D |
| Pang Phillip Chief Medical Officer | 2020-10-21 | Sale | −5,000 | $35.59 | $177,952 | 29,777 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2020-10-21 | Option exercise · Employee Stock Option (Right to Buy) | −7,870 | 92,591 | D | ||
| Pang Phillip Chief Medical Officer | 2020-10-21 | Option exercise · Employee Stock Option (Right to Buy) | −2,315 | 48,612 | D | ||
| Pang Phillip Chief Medical Officer | 2020-10-21 | Option exercise · Employee Stock Option (Right to Buy) | −2,315 | 67,129 | D | ||
| Open-market sales · 12,500 sh · avg $35.49 · $443,608 | |||||||
Loading xslF345X03/doc4.xml…